Thus, it is likely that multiple cellular sources contribute to elevated IL-6 levels, although the contribution of each cell type may depend on the type of PAH, the severity of the disease, and individual patient differences given the heterogeneous nature of PAH. This evidence concerns the gene IL6 and pulmonary arterial hypertension.